CLINICAL_TRIALS
research
· 2026-04-08
Clinical Trial Update: The PROTECT-HIE Pilot Trial [Phase 2]
Summary
A Phase 2 pilot clinical trial called PROTECT-HIE for hypoxic-ischemic encephalopathy is currently listed as not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Hypoxic-ischemic Encephalopathy (HIE) | Phase 2 | Status: NOT_YET_RECRUITING